Immunome Inc. planned insider sales
In the last twelve months insiders at Immunome Inc. filed 15 Form 144 notices of planned sales, 834,948 shares worth $22.0 million at the time of filing, from 8 sellers. The latest, filed 11 September 2026: Higgins Jack (officer), 13,200 shares worth $334,224, planned for around 11 September 2026 through Fidelity Brokerage Services LLC. One notice's value as filed does not match the share price that day; it is marked in the table.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 11 September 2026 | Higgins Jack | Officer | 13,200 | $334,224 | 11 September 2026 | 13,200 shares from 11 September 2026 | Fidelity Brokerage Services LLC | Stock Option Exercise | Form 144 |
| 12 August 2026 | Barchas Isaac | Director | 11,048 | $301,058 | 12 August 2026 | 73,339 shares from 11 August 2026 | Fidelity Brokerage Services LLC | Investment Distribution | Form 144 |
| 6 August 2026 | Abhmc Ii, LLC | Shareholder | 108,504 | $2.8 million | 6 August 2026 | None on Form 4 yet | Merrill Lynch | Private Placement | Form 144 |
| 4 August 2026 | Horn Kinney | Officer | 90,616 | $2.3 million | 4 August 2026 | 90,616 shares from 4 August 2026 | Fidelity Brokerage Services LLC | Stock Option Exercise | Form 144 |
| 7 July 2026 | Horn Kinney | Officer | 1,092 | $27,300 | 7 July 2026 | 1,092 shares from 7 July 2026 | Fidelity Brokerage Services LLC | Stock Option Exercise | Form 144 |
| 6 July 2026 | Abhmc Ii, LLC | Shareholder | 100,000 | $2.4 million | 6 July 2026 | No matching Form 4 sale | Merrill Lynch | Private Placement | Form 144 |
| 2 July 2026 | Lechleider Robert | Officer | 55,000 | $1.2 million | 2 July 2026 | 55,000 shares from 2 July 2026 | Fidelity Brokerage Services LLC | Stock Option Exercise | Form 144 |
| 2 July 2026 | Abhmc Ii, LLC | Shareholder | 100,000 | $2.1 million | 2 July 2026 | No matching Form 4 sale | Merrill Lynch | Private Placement | Form 144 |
| 30 June 2026 | Arsenal Bridge Venture II-B, LLC | Shareholder | 1,050 | $22,092 | 30 June 2026 | No matching Form 4 sale | Merrill Lynch | Private Placement | Form 144 |
| 30 June 2026 | Abhmc Ii, LLC | Shareholder | 100,000 | $2.1 million | 30 June 2026 | No matching Form 4 sale | Merrill Lynch | Private Placement | Form 144 |
| 25 June 2026 | Lechleider Robert | Officer | 55,000 | $1.1 million | 25 June 2026 | 55,000 shares from 25 June 2026 | Fidelity Brokerage Services LLC | Stock Option Exercise | Form 144 |
| 15 June 2026 | Rosett Max | Officer | 60,000 | $1.1 million | 15 June 2026 | 60,000 shares from 15 June 2026 | Fidelity Brokerage Services LLC | Stock Option Exercise | Form 144 |
| 2 April 2026 | Higgins Jack | Officer | 9,438 | $204,238 | 2 April 2026 | 9,438 shares from 2 April 2026 | Fidelity Brokerage Services LLC | Stock Option Exercise | Form 144 |
| 2 April 2026 | Rosett Max | Officer | 65,000 | $4.7 million value as filed; does not match the share price that day | 2 April 2026 | 65,000 shares from 2 April 2026 | Fidelity Brokerage Services LLC | Merger Payout; Option Granted 03/23/2023; Stock Option Exercise | Form 144 |
| 20 March 2026 | Wagenheim Philip | Director | 65,000 | $1.4 million | 20 March 2026 | 65,000 shares from 20 March 2026 | RBC CAPITAL MARKETS LLC | SHARE TRANSFER | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.